DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Takegawa N, Nonagase Y, Yonesaka K. et al.
DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.

Int J Cancer 2017;
141: 1682-1689

Download Bibliographical Data

Search in:
Access:
Access: